<DOC>
	<DOCNO>NCT01114087</DOCNO>
	<brief_summary>Evaluate possible deleterious effect tyrosine kinase inhibitor sperm concentration , 6 month therapy , correspond 2 cycle spermatogenesis sperm nuclear integrity . The main comparison criterion mean difference sperm concentration 6 month treatment .</brief_summary>
	<brief_title>Impact Inhibitors Tyrosine Kinase Male Fertility</brief_title>
	<detailed_description>Antityrosine - kinase , imatinib presently gold standard therapy chronic myeloid leukaemia ( CML ) , complete cytogenetic response achieve 70-90 % patient receive drug first -line monotherapy . Imatinib selectively inhibit hybrid oncogen BCR/ABL involve genesis CML tyrosine kinase , c-kit platelet derive growth factor receptor ( PGDF-R ) , involve malignant gastro intestinal stromal tumour ( GIST ) . Despite good tolerance , vivo animal study prove imatinib induces teratogenesis dose-related effect spermatogenesis . In human , pregnancy involve male CML patient report one spontaneous abortion , one case gut malrotation 15 healthy child . However , absence detail definite evidence lack deleterious effect imatinib spermatogenesis sperm nuclear integrity human , specific study warrant . Male patient ( 38 ) include study 18 60 year old , present chronic myeloid leukaemia malignant GIST receive first time treatment imatinib , tyrosin-kinase inhibitor , precede hydroxyurea therapy le one month . These patient sign informed consent cover French social security system . In open prospective study , patient control . The effect imatinib spermatogenesis evaluate concentration spermatozoon begin treatment 6 month imatinib , represent 2 cycle spermatogenesis . Patients recruit onco-haematologists ( 5 correspond centre ) refer CECOS Tenon . A medical investigator collect inform consent fill study file . A classical sperm analysis , accord OMS , perform . A sample ejaculate fix analysis percentage sperm nuclei fragment DNA ( TUNEL procedure ) . The rest semen freeze , package straw store liquid nitrogen use , necessary , patient ART mandatory conceive child.Another sperm recovery perform period 6 month anti tyrosine-kinase ( ATK ) therapy sperm analysis carry result compare first evaluation , ATK . The plasmatic concentration imatinib determine , patient , day second sperm recovery check efficiency ATK administration .</detailed_description>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Men 18 60 year old Patients recently diagnose CML GIST Patients treatment inhibitor tyrosine kinase monotherapy prescribe Patients sign informed consent Patients social security Patients already subject treatment potentially sterilize Patients supervision guardianship</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Spermatogenesis</keyword>
	<keyword>Inhibitors tyrosine kinase</keyword>
	<keyword>Fragmentation spermatic DNA</keyword>
</DOC>